Pursuant to provisions of Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulation 2015 this is to inform you that the Board of Directors of the Company at its meeting held today i.e. February 14 2024 inter alia considered and approved Unaudited Standalone and Consolidated Financial Results of the Company for the quarter and nine months ended on December 31 2023 along with Limited Review Report issued by M/s. V Goswami & Co Statutory Auditors of the Company.Further please find enclosed Standalone and Consolidated Unaudited Financial Results along with Limited Review Report for the quarter and nine months ended on December 31 2023 as Annexure 1 and same is also available on the website of the Company viz. www.medicointercontinental.com.The Board Meeting of the Company commenced at 12:30 PM and concluded at 12:55 PM.
Ask Value Research 
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.
